CHRISTINE DOMINGUEZ: Open Payments
NPI 1124415872 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 13 payments from 6 companies in 2025. Trend: 2023 $812 · 2024 $704 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $118 |
| Novo Nordisk Inc | 3 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Exact Sciences Corporation | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: BOTOX, CAPLYTA, Ozempic, XIFAXAN, QULIPTA, Cologuard Collection Kit, TRELEGY ELLIPTA.
Industry payments across LA — which companies pay providers there.
